ALLMedicine™ Hepatocellular Carcinoma Center
Research & Reviews 28,769 results
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10024539
Journal of Hepatocellular Carcinoma; Chen Y, Wu X et. al.
Mar 22nd, 2023 - Hepatocellular carcinoma (HCC) was the sixth most prevalent cancer worldwide. Long non-coding RNA TGFB2-OT1 has been proven to mediate inflammation and autophagy in vascular endothelial cells. However, its function in HCC is still unknown. We anal...
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10024628
Canadian Journal of Gastroenterology & Hepatology; Donath H, Wölke S et. al.
Mar 22nd, 2023 - Ataxia-telangiectasia (A-T) is a rare autosomal-recessive multisystem disorder characterized by pronounced cerebellar ataxia, telangiectasia, cancer predisposition, and altered body composition. Liver diseases with steatosis, fibrosis, and hepatoc...
https://doi.org/10.1002/cncr.34754
Cancer Abou-Alfa GK, Wang X et. al.
Mar 22nd, 2023 - Clinical trials suggest α-fetoprotein (AFP) reduction may be prognostic among patients with advanced hepatocellular carcinoma. However, the association of AFP reduction with outcomes in real-world settings is unclear. Patients with advanced hepato...
https://doi.org/10.1007/s12024-023-00601-w
Forensic Science, Medicine, and Pathology; Ishigami A, Inaka S et. al.
Mar 22nd, 2023 - We report a case of hemoperitoneum after percutaneous radiofrequency ablation in a patient with hepatocellular carcinoma. A 60-year-old female was hospitalized for the treatment of thrombasthenia and cirrhosis caused by chronic Hepatitis C, and co...
https://doi.org/10.1007/s00535-023-01982-z
Journal of Gastroenterology; Gao TM, Zhou J et. al.
Mar 22nd, 2023 - Liver cirrhosis is the highest risk factor for hepatocellular carcinoma (HCC) worldwide. However, etiological therapy is the only option in cirrhosis patients to decrease the HCC risk. The aim of this study was to explore whether laparoscopic sple...
Guidelines 42 results
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9847974
PloS One; Gaugain L, Cawston H et. al.
Jan 19th, 2023 - The IMbrave150 clinical trial assessed the efficacy and safety of atezolizumab in combination with bevacizumab (ATZ+BVA) versus sorafenib in adults with advanced/unresectable hepatocellular carcinoma, who have not received prior systemic treatment...
https://doi.org/10.1053/j.gastro.2022.11.034
Gastroenterology Wang B, Bonkovsky HL et. al.
Jan 16th, 2023 - The acute hepatic porphyrias (AHP) are rare, inborn errors of heme-metabolism and include acute intermittent porphyria, hereditary coproporphyria, variegate porphyria, and porphyria due to severe deficiency of 5-aminolevulinic acid dehydratase. Ac...
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9597235
Clinical and Molecular Hepatology;
Oct 21st, 2022 - Hepatocellular carcinoma (HCC) is the fifth most common cancer worldwide and the fourth most common cancer among men in South Korea, where the prevalence of chronic hepatitis B infection is high in middle and old age. The current practice guidelin...
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9398982
Gastroenterology Long MT, Noureddin M et. al.
Jul 17th, 2022 - Nonalcoholic fatty liver disease (NAFLD) is well recognized as a leading etiology for chronic liver disease, affecting >25% of the US and global populations. Up to 1 in 4 individuals with NAFLD have nonalcoholic steatohepatitis, which is associate...
https://doi.org/10.1016/j.jhep.2022.03.033
Journal of Hepatology; ,
Jun 7th, 2022 - Haemochromatosis is characterised by elevated transferrin saturation (TSAT) and progressive iron loading that mainly affects the liver. Early diagnosis and treatment by phlebotomy can prevent cirrhosis, hepatocellular carcinoma, diabetes, arthropa...
Drugs 31 results see all →
Clinicaltrials.gov 2,373 results
https://clinicaltrials.gov/ct2/show/NCT04518748
Mar 10th, 2023 - Selective Internal Radiation Therapy (SIRT) is a technique where radiation is internally delivered to a tumor. In SIRT, small radioactive beads are deposited in the liver through a large blood vessel (hepatic artery). SIRT that uses the radioactiv...
https://clinicaltrials.gov/ct2/show/NCT05763277
Mar 10th, 2023 - The prognosis of hepatocellular carcinoma is poor compared to other carcinomas. Many drugs have recently been developed, and recently, atezolizumab-bevacizumab treatment was superior to sorafenib, the conventional treatment for advanced hepatocell...
https://clinicaltrials.gov/ct2/show/NCT04851119
Mar 10th, 2023 - PRIMARY OBJECTIVES: I. To estimate the maximum tolerated dose (MTD) and/or recommended phase 2 dose (RP2D) of tegavivint administered as an intravenous (IV) infusion over 4 hours, once weekly for 3 weeks, followed by a 1 week rest, in a 28-day cyc...
https://clinicaltrials.gov/ct2/show/NCT04039607
Mar 10th, 2023 - The main purpose of this study is to compare the overall survival (OS) of nivolumab plus ipilimumab versus standard of care (SOC) (sorafenib or lenvatinib) in all randomized participants with advanced hepatocellular carcinoma (HCC) who have not re...
https://clinicaltrials.gov/ct2/show/NCT05199285
Mar 10th, 2023 - PRIMARY OBJECTIVE: I. To investigate the confirmed objective response rate (ORR) of nivolumab and ipilimumab in patients with hepatocellular carcinoma (HCC) who have progressed radiographically on atezolizumab/bevacizumab that necessitates change ...
News 2,422 results
https://www.mdedge.com/gihepnews/article/261682/liver-disease/earlier-hep-b-biomarker-clinical-outcomes
Jim Kling, MDedge News
Mar 8th, 2023 - Low serum levels of the hepatitis B core-related antigen (HBcrAg) could be an early biomarker of a functional cure of a hepatitis B infection, according to new findings from a retrospective study. A drop in HBcrAg predicted the seroclearance of he.
https://www.mdedge.com/hematology-oncology/article/260884/gastrointestinal-cancer/adding-sbrt-sorafenib-boosts-survival
Roxanne Nelson, RN, BSN
Jan 27th, 2023 - SAN FRANCISCO – Adding stereotactic body radiation therapy (SBRT) to sorafenib produced better outcomes among patients with hepatocellular carcinoma (HCC) than sorafenib alone, according to new findings. The use of SBRT in this setting improved bo.
https://www.mdedge.com/dermatology/article/260792/pigmentation-disorders/pigmentary-disorder-experts-welcome-research
Tom Collins
Jan 25th, 2023 - ORLANDO – Research on pigmentary disorders has entered an overdue era of increased attention, resulting in more treatment options and the promise of improved quality of life for patients, a panel of experts said in a session on this topic at the O.
https://www.mdedge.com/hematology-oncology/article/260791/gastrointestinal-cancer/palliative-radiotherapy-successfully
Randy Dotinga
Jan 25th, 2023 - Most patients with end-stage hepatocellular carcinoma experience pain, but when it’s severe, how best to control the pain is debatable. A number of studies, including one recently presented at the ASCO Gastrointestinal Cancers Symposium 2023, show.
https://www.medpagetoday.com/hematologyoncology/othercancers/102730
Jan 20th, 2023 - The CDC added uterine cancer to the list of covered World Trade Center-related conditions; women enrolled in the World Trade Center Health Program will have access to cancer care and treatment if their uterine cancer is related to 9/11 exposures. ...